Emulate Launches AVA™ Emulation System to Accelerate Drug Development With First-of-its-Kind High-Throughput Organ-Chip Platform

Emulate Launches AVA™ Emulation System to Accelerate Drug Development With First-of-its-Kind High-Throughput Organ-Chip Platform

BOSTON--(BUSINESS WIRE)--Jun 10, 2025-

Biocurious: Clever Culture Systems has a lot on its ‘plate’ as it revolutionises quality control in drug making

Clever Culture’s AI-enabled APAS Independence device automates the arduous process of agar plate reading at large drug facilities Having attracted Astrazeneca as a foundation client, the company is talking to at least 14 more Big Pharma players The company will expand APAS usage from so-called ‘settled’ agar plates to ‘contact’ plates   Reports of big pharmaceutical companies expanding their manufacturing footprint are music to the ears of Cleve…

Emulate Launches AVA Emulation System to Boost Drug Development

Emulate, Inc., one of the world leaders in Organ-on-a-Chip technology, announced the commercial launch of the AVA Emulation System, a self-contained instrument that cultures, incubates, and images up to 96 independent Organ-Chip samples in a single run. AVA delivers an unprecedented magnitude of in vivo-level insights faster than animal models while cutting consumable costs four-fold and in-lab labor by half compared to current generation techno…